Analysis of genomic alterations in cancer associated human pancreatic stellate cells.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
08 08 2022
08 08 2022
Historique:
received:
24
04
2021
accepted:
30
07
2022
entrez:
8
8
2022
pubmed:
9
8
2022
medline:
11
8
2022
Statut:
epublish
Résumé
Pancreatic stellate cells (PSCs) constitute important cells of the pancreatic microenvironment and their close interaction with cancer cells is important in pancreatic cancer. It is currently not known whether PSCs accumulate genetic alterations that contribute to tumor biology. Our aim was to analyze genetic alterations in cancer associated PSCs. PSC DNA was matched to DNA isolated from pancreatic cancer patients' blood (n = 5) and analyzed by Next-Generation Sequencing (NGS). Bioinformatic analysis was performed using the GATK software and pathogenicity prediction scores. Sanger sequencing was carried out to verify specific genetic alterations in a larger panel of PSCs (n = 50). NGS and GATK analysis identified on average 26 single nucleotide variants in PSC DNA as compared to the matched blood DNA that could be visualized with the Integrative Genomics Viewer. The absence of PDAC driver mutations (KRAS, p53, p16/INK4a, SMAD4) confirmed that PSC isolations were not contaminated with cancer cells. After filtering the variants, using different pathogenicity scores, ten genes were identified (SERPINB2, CNTNAP4, DENND4B, DPP4, FGFBP2, MIGA2, POLE, SNRNP40, TOP2B, and ZDHHC18) in single samples and confirmed by Sanger sequencing. As a proof of concept, functional analysis using control and SERPINB2 knock-out fibroblasts revealed functional effects on growth, migration, and collagen contraction. In conclusion, PSC DNA exhibit a substantial amount of single nucleotide variants that might have functional effects potentially contributing to tumor aggressiveness.
Identifiants
pubmed: 35941161
doi: 10.1038/s41598-022-17748-1
pii: 10.1038/s41598-022-17748-1
pmc: PMC9360052
doi:
Substances chimiques
Nucleotides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13532Informations de copyright
© 2022. The Author(s).
Références
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Nat Med. 2016 May;22(5):497-505
pubmed: 27089513
Nat Rev Dis Primers. 2016 Apr 21;2:16022
pubmed: 27158978
Neoplasia. 2009 May;11(5):497-508
pubmed: 19412434
Front Physiol. 2018 Jun 18;9:754
pubmed: 29967585
J Thromb Haemost. 2020 Nov;18(11):2968-2975
pubmed: 32780555
Mol Cancer. 2010 Apr 23;9:88
pubmed: 20416094
Trends Genet. 2011 Jun;27(6):217-23
pubmed: 21496937
Gut. 2012 Feb;61(2):172-8
pubmed: 22115911
Oncogene. 2017 Jul 27;36(30):4288-4298
pubmed: 28346421
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
BMC Res Notes. 2014 Mar 13;7:144
pubmed: 24625073
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Genet. 2007 Jul;39(7 Suppl):S43-7
pubmed: 17597781
Pancreas. 2015 Mar;44(2):216-20
pubmed: 25479588
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Gastroenterology. 1998 Aug;115(2):421-32
pubmed: 9679048
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
NPJ Precis Oncol. 2019 Mar 6;3:7
pubmed: 30854468
Genome Res. 2010 Nov;20(11):1469-81
pubmed: 20841430
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Cancer Res. 2008 Apr 1;68(7):2085-93
pubmed: 18381413
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Oncogene. 2005 Jun 23;24(27):4421-32
pubmed: 15856026
Gastroenterology. 2013 Jun;144(6):1210-9
pubmed: 23622130
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634